ALS Research
ALS Faculty at lab bench

From bench to bedside

Leading the way in ALS research.


An unparalleled research team with collaborators across the globe leverages basic science, clinical, and observational studies to work towards alleviating suffering in ALS and one day making it a preventable disease.

Our Key Moments
Our ALS program launches
The overarching goal? Develop ALS therapies. We investigate the potential of insulin-like growth factor I for slowing the death of motor neurons (those involved in ALS).
ohoto of feldman lab in early 2000s ohoto of feldman lab in early 2000s
Research initiatives
photo of a busy street in chinatown with fast food and paint shops
The Exposome

How exposures experienced over a lifetime—from pollution to diet—affect ALS risk and survival.

Learn More
immunology
Immunology

Studying the immune system and ALS to identify more effective therapies.

Learn More
population
Observational Studies

Following people over time to understand who gets ALS what exposures affect ALS risk, as well as brain health.

Learn More
The Biorepository

The ALS Biorepository began in 2012 and currently houses over 20,000 samples from over 1,000 patients (both those with ALS and healthy controls). Samples stored include white blood cells, isolated RNA, isolated DNA, plasma, urine, fecal samples and fibroblast lines, as well as spinal cords from patients who died from ALS. Not only do we use the biorepository for our own ALS research, but samples are shared with top institutions worldwide.

Clinical Trials
Publications